ReviewFrontiers in veterinary science2026
Interdisciplinary insights on selection, surveillance and mitigations of antimicrobial resistance dynamics on a UK dairy farm with relevance to other one health sectors.
Review in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic use in agriculture is a global driver for antimicrobial resistance (AMR). Dairy farming, one of the largest producers of agricultural waste, represents a critical opportunity for mitigating AMR impacts. We review, synthesize and generalize from results of 10 years of interdisciplinary study of AMR in the waste from a single, medium-sized intensive UK dairy farm and related One Health AMR work. Resistance patterns reflect a combination of (i) short-term stability with (ii) long-term change associated with altered antibiotic use. These dynamics were driven by clonal expansion and contraction characterized by chromosomal carriage of resistance, and co-selection by environmentally stable antimicrobials including copper, zinc and tetracycline, rather than horizontal gene transfer. We outline 10 considerations for study, surveillance and mitigation: (i) the need for long-term longitudinal sampling; (ii) the value of intense focus on representative sites; (iii) inclusion of both Gram-positive and Gram-negative sentinels; (iv) adoption of shared standards for measurement and reporting; (v) use of precise language for AMR hazards to enable appropriate study site selection; (vi) reduction of overall antibiotic use, e.g., through infection control; (vii) continued avoidance of veterinary use of internationally recognized critical human antibiotics; (viii) avoidance of environmentally stable antibiotics such as some tetracyclines; (ix) reduction of co-selection pressure via recovery of metals such as copper and zinc; and (x) mitigation of resistance through storage of slurry without further additions, e.g., through the use of two-tank systems. We propose that these considerations are relevant beyond dairy, applicable in wider livestock, environmental and One Health settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.